Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

PhRMA opposed to Senate drug price control plans

PhRMA opposed to Senate drug price control plans

But has bipartisan support and Trump backing. Long-awaited Senate Finance Committee proposals to tackle high drug prices through Medicare and Medicaid have been slammed by the trade organisation representing pharma ... President Trump – who has

Latest news

  • Another setback on pricing as Trump drops rebate plans Another setback on pricing as Trump drops rebate plans

    Based on careful analysis and thorough consideration, the President has decided to withdraw the rebate rule,” said a White House spokesman. ... spokesman. “President Trump will consider using any and all tools to ensure that prescription drug costs

  • Trump presses on with reference pricing plan for medicines Trump presses on with reference pricing plan for medicines

    Proposed pilot programme to run until 2025. President Donald Trump says he is working on an executive order that will peg the price the US is prepared to pay for medicines ... Trump says he will publish the order “very shortly”, but for now what is

  • Trump backtracks on ‘NHS on the table’ comments Trump backtracks on ‘NHS on the table’ comments

    to the NHS – President Donald Trump abruptly reversed his stance. ... Fast forward a few hours, and Trump backtracked on his earlier position when challenged in an interview with Piers Morgan on ITV’s Good Morning Britain programme.

  • Hancock says “NHS not for sale” in post-Brexit US trade talks Hancock says “NHS not for sale” in post-Brexit US trade talks

    Tensions rise as President Trump arrives for state visit. Freer access to the NHS will be part of any post-Brexit US-UK trade deal, according to US Ambassador Woody Johnson. ... President broke diplomatic convention by saying that Boris Johnson would

  • Tit for tat as PBMs blame pharma for high drug prices Tit for tat as PBMs blame pharma for high drug prices

    Doing away with rebates is one of the main elements in President Trump’s plan to reduce drug prices, and the PBMs – often referred to as the ‘middlemen’ in the drug ... Yesterday, the PBMs struck back, with Humana’s president of healthcare

More from news
Approximately 7 fully matching, plus 55 partially matching documents found.

Latest Intelligence

  • The fight for affordable insulin The fight for affordable insulin

    Where previous administrations were opposed to importation from Canada and elsewhere, the Trump White House says it is in favour of individuals resorting to these measures, but wants to legislate to ... Recent weeks have seen President Trump shift his

  • The Orkambi blame game The Orkambi blame game

    These included questions to Jeff Leiden about his salary, the company’s profits and taxes paid in the UK, and allegations from President Trump that European countries such as the UK

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics